Cargando…

What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?

Detalles Bibliográficos
Autor principal:	Wilder-Smith, Annelies
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554481/ https://www.ncbi.nlm.nih.gov/pubmed/34756187 http://dx.doi.org/10.1016/S1473-3099(21)00690-3

Ejemplares similares

SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
por: Thiruvengadam, Ramachandran, et al.
Publicado: (2022)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants
por: Lechien, Jérôme R, et al.
Publicado: (2022)

Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
por: Sigal, Alex, et al.
Publicado: (2022)

Managing waning vaccine protection against SARS-CoV-2 variants
por: Leung, Kathy, et al.
Publicado: (2022)

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
por: Wang, Stephen Y, et al.
Publicado: (2022)

SARS-CoV-2 vaccine-induced antibody levels: what lies beneath
por: Lassaunière, Ria, et al.
Publicado: (2022)

Understanding the drivers of transmission of SARS-CoV-2
por: Cornelissen, Laura, et al.
Publicado: (2021)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

Impact of BMI on COVID-19 vaccine effectiveness
por: Wilder-Smith, Annelies, et al.
Publicado: (2022)

Impact of contact tracing on SARS-CoV-2 transmission
por: Sun, Kaiyuan, et al.
Publicado: (2020)

Assessing the potential for fomite transmission of SARS-CoV-2
por: Short, Kirsty R, et al.
Publicado: (2023)

Decoding the next SARS-CoV-2 variant
por: Nel, Jeremy, et al.
Publicado: (2022)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

Optimising dengue pre-vaccination screening
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

SARS-CoV-2 variants offer a second chance to fix vaccine inequities
por: Hotez, Peter J.
Publicado: (2022)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

COVID-19 vaccines in the age of the delta variant
por: Wheatley, Adam K, et al.
Publicado: (2022)

COVID-19 vaccine impact in Israel and a way out of the pandemic
por: Leshem, Eyal, et al.
Publicado: (2021)

Targeted mass testing and phylogenetic analysis is effective for preventing community transmission of SARS‐CoV‐2 beta variant
por: Tokuda, Yasuharu, et al.
Publicado: (2022)

Assessment of SARS-CoV-2 replication in the context of other respiratory viruses
por: Belser, Jessica A
Publicado: (2020)

Aerosol generating procedures: are they of relevance for transmission of SARS-CoV-2?
por: Hamilton, Fergus, et al.
Publicado: (2021)

Effect of vaccination on household transmission of SARS-CoV-2 Delta variant of concern
por: Lyngse, Frederik Plesner, et al.
Publicado: (2022)

Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants
por: Kim, Yong Chan, et al.
Publicado: (2022)

Global emergence of SARS-CoV-2 variants: new foresight needed for improved vaccine efficacy
por: Yadav, Pragya D, et al.
Publicado: (2022)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

Importance of precise data on SARS-CoV-2 transmission dynamics control
por: Rybniker, Jan, et al.
Publicado: (2020)

Ten scientific reasons in support of airborne transmission of SARS-CoV-2
por: Greenhalgh, Trisha, et al.
Publicado: (2021)

The role of schools and school-aged children in SARS-CoV-2 transmission
por: Flasche, Stefan, et al.
Publicado: (2021)

SARS-CoV-2 transmission: time to rethink public health strategy
por: Parker, Arifa, et al.
Publicado: (2022)

SARS-CoV-2 variants and ending the COVID-19 pandemic
por: Fontanet, Arnaud, et al.
Publicado: (2021)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

SARS-CoV-2 evolution and vaccines: cause for concern?
por: Williams, Thomas C, et al.
Publicado: (2021)

Stroke after SARS-CoV-2 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
por: Meyerowitz, Eric A., et al.
Publicado: (2022)

Airborne transmission of the Delta variant of SARS-CoV-2 in an auditorium
por: Huang, Jianxiang, et al.
Publicado: (2022)

Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population
por: Avila-Ponce de León, Ugo, et al.
Publicado: (2022)

Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
por: Hsu, L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ngf23s67mqvafl14ejl66st0j